Global Anorectal Disorders Treatment Market Size, Share, Growth Analysis Report - Forecast 2034

Anorectal Disorders Treatment Market: Industry Perspective

The global anorectal disorders treatment market size was worth around USD 4.37 Billion in 2024 and is predicted to grow to around USD 7.83 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 6% between 2025 and 2034.

The report analyzes the global anorectal disorders treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the anorectal disorders treatment industry.

Request Free Sample

Anorectal Disorders Treatment Market: Overview

Anorectal disorders are medical conditions related to the rectum or anus. The anorectal disorders treatment industry deals with various types of medications and therapies used for the treatment of the associated condition or managing the symptoms which range from pain, itching, bleeding, and difficulty with bowel movements. The treatment for anorectal disorders depends on the specific concern along with its severity. The different types of conditions include anal fissures, warts, anal abscesses and fistulas, and fecal incontinence. The market deals with the segment that focuses on providing services and products for the management, diagnosis, and treatment of these conditions. It includes medical devices, surgical instruments, pharmaceuticals, and therapeutic procedures. The industry stakeholders offer a range of treatment options depending on the patient's condition.

Key Insights

• As per the analysis shared by our research analyst, the global anorectal disorders treatment market is estimated to grow annually at a CAGR of around 6% over the forecast period (2025-2034).
• Regarding revenue, the global anorectal disorders treatment market size was valued at around USD 4.37 Billion in 2024 and is projected to reach USD 7.83 Billion by 2034.
• The anorectal disorders treatment market is projected to grow at a significant rate due to rising global geriatric population, increasing prevalence of anorectal conditions, growing awareness about gastrointestinal health, and advancements in treatment options including minimally invasive procedures.
• Based on Disease, the Diarrhea segment is expected to lead the global market.
• On the basis of Treatment, the Drugs segment is growing at a high rate and will continue to dominate the global market.
• Based on the Route of Administration, the Oral segment is projected to swipe the largest market share.
• By End User, the Hospitals segment is expected to dominate the global market.
• In terms of Distribution Channel, the Hospital Pharmacy segment is anticipated to command the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Anorectal Disorders Treatment Market: Growth Drivers

Increasing prevalence of anorectal disorders to propel market growth

The global anorectal disorders treatment market is projected to grow owing to the increasing prevalence of the condition. The onset of the associated diseases is related to several causes and depends on the particular type of condition diagnosed by the medical professional. Hemorrhoids, for instance, are swollen blood vessels present in the anus or rectum. Several factors can contribute to the conditions including straining during bowel movement, chronic constipation or diarrhea, pregnancy & childbirth, obesity, and generic impact. In the same way, fecal incontinence which refers to the inability to control bowel movement is known to be caused by a variety of underlying issues such as inflammatory bowel disease, chronic diarrhea, weak or damaged sphincter muscles, or nerve damage. With the increasing number of people suffering from different types of anorectal disorders, the market is projected to grow.

Anorectal Disorders Treatment Market: Restraints

Lack of awareness and social stigma to restrict market expansion

Despite the medical community expanding its reach worldwide by running multiple explanatory and awareness-generating programs, there are several medical diseases that lead to a sense of social stigma which leads to the patients suffering silently for multiple years. Anorectal disorders are a set of such conditions that either go unmentioned or there is a significant lack of awareness amongst the patient group which restricts the global anorectal disorders treatment market expansion.

Anorectal Disorders Treatment Market: Opportunities

Increasing efforts undertaken by healthcare agencies to provide growth opportunities

The world is currently witnessing a surge in several activities that aim to remove social discomfort related to certain medical conditions. These programs are undertaken by regional healthcare bodies with the aid of medical professionals and institutes. Such programs are expected to create higher growth opportunities for the anorectal disorders treatment industry during the forecast period. For instance, statistics submitted by Eurostat claim that in 2020, the European member states spent nearly €49.9 billion on preventive health care.

Anorectal Disorders Treatment Market: Challenges

Limited reimbursement policies to challenge the market expansion

One of the key challenges that the global anorectal disorders treatment industry players are expected to come across is the lack of adequate reimbursement policies covering surgical procedures and treatment related to anorectal disorders. This greatly restricts the market growth trajectory since more people may refrain from undergoing expensive treatments and opt for home remedies which may further intensify the condition.

Anorectal Disorders Treatment Market: Segmentation

The global anorectal disorders treatment market is segmented based on end-users, diseases, route of administration, distribution channel, and region.

Based on end-users, the global market segments are specialty clinics, hospitals, and others. In 2022, the industry witnessed the highest growth in the specialty clinics services which include facilities dedicated to gastroenterology, proctology, or colorectal diseases. Specialty clinics are known to be equipped with specific devices and tools required to treat less conventional conditions such as anorectal disorders. These conditions also require specialized care and diagnostic tools. Hospitals are important to the overall market growth because they generally tend to be the primary point of contacting a medical professional. As of 2021, the US healthcare sector was worth more than USD 800 billion.

Based on disease, the anorectal disorders treatment industry segments are rectal prolapse, hemorrhoid, diarrhea, abscess, fistula, fissures, itching, warts, and others.

Based on route of administration, the global market divisions are rectal, parenteral, oral, and others. The most frequently used form of administration in anorectal disorders is the rectal mode along with topical medication. The process involves applying medicine to the affected area and can exist in the form of creams, ointments, suppositories, or medicated wipes. The main aim of such medication is to promote healing, reduce inflammation, and soothe associated symptoms. The rectal route is known to be effective since it provides localized treatment. As estimated, the US elderly population above the age of 85 years is likely to reach 20 million by 2050.

Based on distribution channel, the anorectal disorders treatment industry segments are retail pharmacy, hospital pharmacy, and others.

Anorectal Disorders Treatment Market: Report Scope

Recent Developments:

• In June 2022, GlaxoSmithKline-backed research and trial group announced breakthrough trial reports highlighting the potential for a new drug capable of treating rectal cancer. However, they also mentioned that it is too early to call the drug a cancer cure. In the first phase, it has managed to provide 100 results and more tests are to be followed in the coming years
• In November 2021, Harvard Health Publishing, a unit of the Harvard Medical School, published a detailed article on the causes of external and internal hemorrhoids. In the explanation, they also mentioned the simple ways that can be used to treat the condition. Some of the recommended ways include including fiber-rich food, exercising, and a sitz bath

Anorectal Disorders Treatment Market: Regional Analysis

North America to witness high growth rate

The global anorectal disorders treatment market is projected to witness the highest growth in North America with particular focus on Canada and the US. Factors such as high anorectal disorders prevalence rate along with growing awareness are reasons for higher CAGR in the region. This trend is further strengthened by the establishment of a robust medical or healthcare infrastructure that ensures that every resident of the country has access to quality medical care. The regional governments are already emphasizing reducing the gap that exists in the medical care measures which could lead to further growth in North America. Moreover, the presence of key pharmaceutical players has worked in the favor of the regional market along with large-scale medical device manufacturers. In 2022, the total medical expenditure in Canada reached USD 8,563 per Canadian as per the Canadian Institute of Health Information.

Anorectal Disorders Treatment Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the anorectal disorders treatment market on a global and regional basis.

The global anorectal disorders treatment market is dominated by players like:

• AKORN INC.
• Novartis AG
• Mylan N.V.
• GlaxoSmithKline plc.
• Ferndale Pharma Group Inc.
• F. Hoffmann-La Roche Ltd
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Merck & Co. Inc.
• Sun Pharmaceutical Industries Ltd.
• NATCO Pharma Limited
• LUPIN
• Teva Pharmaceutical Industries Ltd
• Boehringer Ingelheim International GmbH
• AbbVie Inc.
• Allergan
• Aboott and Bayer AG

The global anorectal disorders treatment market is segmented as follows;

By Disease

• Diarrhea
• Hemorrhoid
• Abscesse
• Fistula
• Itching
• Fissures
• Rectal Prolapse
• Warts
• Others

By Treatment

• Drugs
• Surgery
• Others

By Route of Administration

• Oral
• Parenteral
• Rectal
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America